Investigating the effect of Sevelamer drug in patients poisoned with rice tablets

Investigating the effect of Sevelamer drug in patients poisoned with rice tablets and the results of the mentioned treatment

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250202064599N1

Enrollment

Registered

2025-02-18

Start date

2025-03-10

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rice pill poisoning. poisoning

Interventions

Intervention group: Patients will initially receive two 800 mg Solamer tablets. Depending on the patients condition, the dosage may be increased to 9 800 mg Solamer tablets, equivalent to 2.7 grams, d

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with a definitive diagnosis of rice tablet poisoning based on history

Exclusion criteria

Exclusion criteria: Patients with irreversible critical conditions such as cardiac arrest Severe underlying diseases such as advanced renal failure, severe hepatic failure Known sensitivity to Solamer or similar compounds Lack of cooperation from the patient or companions

Design outcomes

Primary

Measure	Time frame
Patient survival. Timepoint: End of intervention. Method of measurement: Using the Kaplan-Meier model.	—

Secondary

Measure	Time frame
CBC, SGOT, SGPT, ABG, BUN, Creatinin, PT, PTT, INR, ALT, AST, LDH, bilubin, ALP and CKMB tests. Timepoint: Daily for up to seven days. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSolmaz Kargarfard

Shiraz University of Medical Sciences

s.kargarfard@sums.ac.ir+98 71 3230 5884

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026